Zhao, Yu-tong
Yuan, Ye
Tang, Yu-guang
Zhang, Shu-wei
Zhou, Hai
Xie, Zong-yi
Article History
Received: 7 October 2023
Revised: 30 November 2023
Accepted: 6 January 2024
First Online: 13 January 2024
Declarations
:
: The study was approved by the ethical standards of the institutional review board of the Massachusetts Institute of Technology (no. 53032805), the local institutional review boards (The National Drug Clinical Trial Institution, clinical study approval number: 2023-6), and the requirement for consent was waived.
: All authors declare that they have no conflict of interest.